Sonnet BioTherapeutics Holdings, Inc. (SONN)

SONN Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year Ending	Current	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	5	5	6	15	35	7
Market Cap Growth	-21.62%	-21.17%	-57.94%	-56.87%	382.25%	51.71%
Enterprise Value	1	3	4	-12	28	7
PE Ratio	-	-0.27	-0.21	-0.60	-0.53	-1.49
PS Ratio	47.83	33.93	18.18	31.27	-	-
PB Ratio	1.45	-22.19	-2.51	0.68	11.61	-2.56
P/FCF Ratio	-0.44	-0.23	-0.23	-0.67	-2.23	-3.27
P/OCF Ratio	-0.44	-0.23	-0.23	-0.67	-2.25	-3.27
EV/Sales Ratio	8.83	19.92	10.19	-25.58	-	-
EV/EBITDA Ratio	-0.25	-0.16	-0.12	0.50	-1.16	-1.58
EV/EBIT Ratio	-0.25	-0.16	-0.12	0.50	-1.16	-1.58
EV/FCF Ratio	-0.16	-0.14	-0.13	0.55	-1.79	-3.35
Debt / Equity Ratio	0.06	-0.90	-0.10	0.01	0.12	-0.08
Debt / EBITDA Ratio	-0.02	-0.01	-0.01	-0.01	-0.01	-0.05
Debt / FCF Ratio	-0.01	-0.01	-0.01	-0.01	-0.02	-0.10
Quick Ratio	1.37	0.41	0.37	4.12	1.56	0.01
Current Ratio	1.89	0.86	0.66	4.30	1.62	0.01
Asset Turnover	0.01	0.02	0.03	0.04	0	0
Interest Coverage	-	-	-	-	-	-28.91
Return on Equity (ROE)	-382.20%	-1499.40%	-513.60%	-431.40%	6237.50%	-117.80%
Return on Assets (ROA)	-126.20%	-223.40%	-242.10%	-213.40%	-351.20%	-15.80%
Return on Capital (ROIC)	-392.86%	85153.91%	1299.73%	-112.07%	-718.55%	179.15%
Earnings Yield	-189.97%	-375.51%	-467.20%	-165.20%	-187.09%	-66.99%
FCF Yield	-295.31%	-425.54%	-436.57%	-149.14%	-44.75%	-30.61%
Buyback Yield / Dilution	-550.94%	-425.77%	-147.76%	-160.57%	-76.15%	-3846.36%
Total Shareholder Return	-550.94%	-425.77%	-147.76%	-160.57%	-76.15%	-3846.36%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).